Claims
- 1. A unit dose reagent chamber for use in a test apparatus for the detection of adenosine triphosphate (ATP) or alkaline phosphatase (AP) in a test sample, and wherein a moveable probe is employed to obtain a test sample and to release reagents from the reagent chamber to a test unit, which unit dose chamber comprises:a) a cylinder having a one open end and an other opposite open end; b) a probe-puncturable membrane seal over the one end and the other end of the cylinder to form a sealed compartment; and c) a reagent composition for use in the detection of the test sample and sealed within the sealed compartment, which composition consists essentially of and is selected from the group consisting of: i) a detergent-containing buffered solution to release adenosine triphosphate (ATP) or alkaline phosphatase (AP) from the test sample into the solution for testing; ii) a reaction stopping solution having a pH of 8 to 11; and iii) a luciferin-luciferase or phosphatase substrate reagent tablet.
- 2. The chamber of claim 1 wherein the membrane seal comprises aluminum foil.
- 3. The chamber of claim 1 wherein the reagent composition comprises a phosphoric acid buffer and an anionic or non-ionic detergent.
- 4. The chamber of claim 1 wherein the reagent composition includes a pH indicator.
- 5. In combination, the chamber of claim 1 in a test apparatus for the detection of adenosine triphosphate (ATP) or alkaline phosphatase (AP) in a test sample, which test apparatus includes a luciferin-luciferase or phosphatase substrate reagent for reaction with the released adenosine triphosphate (ATP) or alkaline phosphatase (AP) in the solution.
- 6. The combination of claim 5 wherein the test apparatus includes a longitudinally moveable probe to puncture the membrane seals to carry out the test.
- 7. The combination of claim 5 wherein the test apparatus includes a closed bottom end, transparent test unit at the one end of the test apparatus, and wherein one or more unit dose reagent chambers are longitudinally positioned in the test unit.
- 8. The combination of claim 7 wherein the test unit has an open top end with threads and a closed bottom end, and the test unit is removedly, threadably secured to one end of the test apparatus.
- 9. The combination of claim 8 wherein the top end of the test unit is sealed with a probe-puncturable membrane seal.
- 10. The combination of claim 7 wherein the sealed compartment comprises the buffered-detergent solution and a luciferase and a luciferin reagent in tablet form at the bottom end of the test unit.
- 11. The combination of claim 5 wherein the test apparatus includes a threadable means to move the probe spirally and longitudinally to puncture the membrane seals.
- 12. The chamber of claim 1 wherein the reagent composition includes a biological buffer solution to optimize a reaction for the detection of adenosine triphosphate (ATP) or alkaline phosphatase (AP).
- 13. The chamber of claim 12 wherein the biological buffer comprises tris(hydroxymethyl)aminomethane (TRIS) or tricine.
- 14. A test apparatus for the detection of adenosine triphosphate (ATP) or alkaline phosphatase (AP) in a test sample, by luminescence or color, which test apparatus comprises:a) a longitudinal test apparatus housing having a one end and an other end; b) a moveable probe within the housing to collect a test sample and arranged to puncture a membrane seal; c) a transparent test unit having a one end and a closed bottom end extending from the one end of the housing for use in detecting luminescence or color in the test sample, and a reagent tablet to detect adenosine triphosphate (ATP) or alkaline phosphatase (AP), by color or luminescence, at the closed bottom end; and d) one or more unit dose reagent chambers longitudinally-positioned in the test unit, which reagent chamber comprises: i) a cylinder having a one open end and an other opposite open end; ii) a probe-puncturable membrane seal at and over the one end and the other end of the cylinder to form a sealed compartment; and iii) a reagent composition for use in the detection of adenosine triphosphate (ATP) or alkaline phosphatase (AP) in the test sample and sealed within the sealed compartment, which reagent composition comprises a buffered solution to release adenosine triphosphate (ATP) or alkaline phosphatase (AP) from the test sample into the solution for subsequent reaction with the reagent tablet.
- 15. The apparatus of claim 14 wherein the membrane seal comprises aluminum foil.
- 16. The apparatus of claim 14 wherein the reagent composition comprises a phosphoric acid and a detergent solution.
- 17. The apparatus of claim 14 wherein the test unit has an open top end with threads and a closed bottom end and is removedly, threadably secured to one end of the test apparatus.
- 18. The apparatus of claim 14 wherein the one end of the test unit is sealed with a probe-puncturable membrane.
- 19. The apparatus of claim 14 wherein the sealed compartment comprises a buffer-detergent solution and a luciferase and a luciferin substrate, as a reagent tablet, is at the bottom end of the test unit.
- 20. The apparatus of claim 14 which includes two sequential reagent unit dose chambers comprising: a first chamber containing the reagent solution to release phosphatase from the probe; and a second chamber containing a reagent for the detection of the phosphatase in the test sample.
- 21. A transparent test unit for use in a test apparatus, for the detection of adenosine triphosphate (ATP) or alkaline phosphatase (AP), and which test unit comprises: a one open end; a closed bottom end; a probe-puncturable membrane over the one end; and the one end having threads for threadable attachment of the test unit to the test apparatus, and the test unit having one or more separate, longitudinally-aligned unit dose reagent chambers, which unit dose chamber comprises:a) a cylinder having a one open end and an other opposite open end; b) a probe-puncturable membrane seal over the one end and the other end of the cylinder to form a sealed compartment; c) a reagent composition for use in the detection of adenosine triphosphate (ATP) or alkaline phosphatase (AP) in the test sample and sealed within the sealed compartment, which comprises a buffered solution to release adenosine triphosphate (ATP) or alkaline phosphatase (AP) from the test sample into the solution; and d) a reagent tablet at the bottom end to detect the adenosine triphosphate (ATP) or alkaline phosphatase (AP) in the solution.
- 22. The test unit of claim 21 wherein the probe-puncturable membrane seal comprises aluminum foil.
- 23. The test unit of claim 21 wherein the test unit includes a luciferin-luciferase reagent tablet.
REFERENCE TO PRIOR APPLICATIONS
This application is a continuation of U.S. patent application Ser. No. 09/093,433, filed Jun. 8, 1998, now U.S. Pat. No. 5,965,453, which application is a continuation of U.S. patent application Ser. No. 08/619,586, filed Mar. 26, 1996, now U.S. Pat. No. 5,827,675, issued Oct. 27, 1998, which application was the U.S. National Stage of International Application No. PCT/US96/00524, filed Jan. 2, 1996, which application claims the benefit of provisional U.S. patent application Ser. No. 60/001,081 filed Jul. 12, 1995, and also the benefit of provisional patent application Ser. No. 60/007,585, filed Nov. 27, 1995.
US Referenced Citations (8)
Foreign Referenced Citations (2)
Number |
Date |
Country |
7-059555 |
Mar 1995 |
JP |
9525948 |
Sep 1995 |
WO |
Provisional Applications (2)
|
Number |
Date |
Country |
|
60/001081 |
Jul 1995 |
US |
|
60/007585 |
Nov 1995 |
US |
Continuations (2)
|
Number |
Date |
Country |
Parent |
09/093433 |
Jun 1998 |
US |
Child |
09/396127 |
|
US |
Parent |
08/619586 |
|
US |
Child |
09/093433 |
|
US |